ESRD patients aged 60-64 years with no insurance or who are on Medicaid are less likely to initiate peritoneal dialysis.
Nearly twice as many patients achieved the target phosphorus range after a year of taking the phosphate binder, regardless of iPTH level.
Ferric pyrophosphate citrate delivered via dialysate or intravenously rapidly donates iron to transferrin and is rapidly cleared from the circulation.
Nearly a quarter of hospitalizations are followed by readmission within 30 days for non-elective reasons.
Study characterizes the link between admission potassium levels and in-hospital mortality overall and among CKD and CVD patients.
Study documents an upswing in emergency department visits and observation stays.
Gout is uncontrolled in the majority of individuals with the condition, data show.
Evidence to date provides no clear answer as to whether early or delayed RRT is the best approach.
Benefits include rapid assessment of kidney size, cortical thickness, and volume status.
Renal and Urology News Articles
- Active Surveillance for Intermediate-risk Prostate Cancer Challenged
- Ferritin Spike Soon After Hemodialysis Initiation Ups Mortality Risk
- Type of Long-term Response to Targeted mRCC Therapy Affects Outcomes
- Add-on Sevelamer Therapy May Improve Hemodialysis Patient Survival
- Iron-based Binder Improves Phosphorus Levels in Dialysis Patients
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)